JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
Cytokinetics
CYTK
$9.12B
| $23.7M | ﹤0.01% |
284,400
-101,701
| -26% | -$3.68M |
2017 Q4
24 quarters
|
|
|
ARCH
1677
DELISTED
Arch Resources, Inc.
ARCH
| $23.7M | ﹤0.01% |
142,968
+10,383
| +8% | +$1.63M |
2016 Q4
28 quarters
|
|
1678
Tenet Healthcare
THC
$20.4B
| $23.7M | ﹤0.01% |
313,649
-114,370
| -27% | -$7.25M |
2013 Q2
42 quarters
|
|
1679
Avantis Emerging Markets Equity ETF
AVEM
$28.4B
| $23.7M | ﹤0.01% |
419,998
+324,293
| +339% | +$17.4M |
2022 Q4
4 quarters
|
|
1680
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.1B
| $23.6M | ﹤0.01% |
251,933
+74,063
| +42% | +$6.51M |
2017 Q4
24 quarters
|
|
1681
Steven Madden
SHOO
$3.34B
| $23.6M | ﹤0.01% |
561,643
+78,379
| +16% | +$2.85M |
2013 Q2
42 quarters
|
|
1682
QCR Holdings
QCRH
$1.63B
| $23.6M | ﹤0.01% |
403,575
+102,352
| +34% | +$5.3M |
2016 Q4
28 quarters
|
|
1683
CALL
Pinduoduo
PDD
$109B
| $23.5M | ﹤0.01% |
+160,500
| New | +$19.5M |
2023 Q4
0 quarters
|
|
1684
East-West Bancorp
EWBC
$17.1B
| $23.5M | ﹤0.01% |
326,142
+40,718
| +14% | +$2.45M |
2013 Q2
42 quarters
|
|
1685
PUT
Nu Holdings
NU
$64.2B
| $23.4M | ﹤0.01% |
+2,814,800
| New | +$22.7M |
2023 Q4
0 quarters
|
|
1686
Invesco NASDAQ 100 ETF
QQQM
$109B
| $23.4M | ﹤0.01% |
138,782
+37,744
| +37% | +$5.89M |
2022 Q4
4 quarters
|
|
1687
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.18B
| $23.3M | ﹤0.01% |
550,552
+145,905
| +36% | +$5.81M |
2021 Q1
11 quarters
|
|
1688
Semtech
SMTC
$17.4B
| $23.3M | ﹤0.01% |
1,064,713
+232,684
| +28% | +$4.32M |
2015 Q4
32 quarters
|
|
1689
iShares Russell Top 200 ETF
IWL
$2.24B
| $23.3M | ﹤0.01% |
202,643
-16,964
| -8% | -$1.84M |
2020 Q3
13 quarters
|
|
1690
UGI
UGI
$7.8B
| $23.3M | ﹤0.01% |
946,256
-30,228
| -3% | -$667K |
2013 Q2
42 quarters
|
|
1691
GlobalFoundries
GFS
$27.1B
| $23.2M | ﹤0.01% |
382,130
-1,115,052
| -74% | -$61.8M |
2021 Q4
8 quarters
|
|
1692
PUT
American Airlines Group
AAL
$8.69B
| $23.1M | ﹤0.01% |
1,684,200
+1,316,500
| +358% | +$16.5M |
2014 Q3
37 quarters
|
|
1693
PUT
Dow Inc
DOW
$19.9B
| $23.1M | ﹤0.01% |
421,900
+51,700
| +14% | +$2.64M |
2020 Q3
13 quarters
|
|
1694
Iovance Biotherapeutics
IOVA
$6.45B
| $23.1M | ﹤0.01% |
2,839,667
+93,311
| +3% | +$488K |
2017 Q2
26 quarters
|
|
1695
Teekay Tankers
TNK
$3.5B
| $23.1M | ﹤0.01% |
461,283
+60,673
| +15% | +$2.91M |
2021 Q2
10 quarters
|
|
1696
CALL
Procter & Gamble
PG
$334B
| $23M | ﹤0.01% |
156,800
+28,400
| +22% | +$4.21M |
2014 Q3
37 quarters
|
|
1697
CALL
Nike
NKE
$52.1B
| $23M | ﹤0.01% |
211,400
+37,400
| +21% | +$4.02M |
2016 Q1
31 quarters
|
|
1698
WisdomTree US LargeCap Dividend Fund
DLN
$6.15B
| $22.9M | ﹤0.01% |
345,044
+100,474
| +41% | +$6.31M |
2015 Q4
32 quarters
|
|
1699
iShares MSCI Australia ETF
EWA
$1.2B
| $22.9M | ﹤0.01% |
938,973
+239,010
| +34% | +$5.3M |
2013 Q2
42 quarters
|
|
1700
Avient
AVNT
$3.72B
| $22.9M | ﹤0.01% |
549,726
+35,656
| +7% | +$1.24M |
2015 Q4
32 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.